Skye Bioscience, Inc. (SKYE)
SKYE has a market cap or net worth of $1.51 billion. The enterprise value is $1.51 billion.
SKYE has 971.55 million shares outstanding. The number of shares has increased by 297.27% in one year.
|Shares Change (YoY)||+297.27%|
|Shares Change (QoQ)||+102.78%|
|Owned by Insiders (%)||18.26%|
|Owned by Institutions (%)||0.21%|
|EV / Earnings||n/a|
|EV / Sales||n/a|
|EV / EBITDA||n/a|
|EV / EBIT||n/a|
|EV / FCF||n/a|
The company has a current ratio of 0.19, with a Debt / Equity ratio of 2.61.
|Debt / Equity||2.61|
|Debt / EBITDA||n/a|
|Debt / FCF||n/a|
Return on equity (ROE) is -2,584.07% and return on invested capital (ROIC) is -652.31%.
|Return on Equity (ROE)||-2,584.07%|
|Return on Assets (ROA)||-280.73%|
|Return on Capital (ROIC)||-652.31%|
|Revenue Per Employee||n/a|
|Profits Per Employee||-$3.98M|
In the past 12 months, SKYE has paid $987,206 in taxes.
|Effective Tax Rate||n/a|
Stock Price Statistics
The stock price has increased by +8,757.14% in the last 52 weeks. The beta is 0.91, so SKYE's price volatility has been similar to the market average.
|52-Week Price Change||+8,757.14%|
|50-Day Moving Average||2.40|
|200-Day Moving Average||0.67|
|Relative Strength Index (RSI)||40.53|
|Average Volume (30 Days)||213,738|
Short Selling Information
|Short Previous Month||n/a|
|Short % of Shares Out||n/a|
|Short % of Float||n/a|
|Short Ratio (days to cover)||n/a|
|Earnings Per Share (EPS)||-$10.51|
The company has $5.13 million in cash and $4.43 million in debt, giving a net cash position of $699,896 or $0.00 per share.
|Cash & Cash Equivalents||5.13M|
|Net Cash Per Share||$0.00|
|Equity / Book Value||1.70M|
|Book Value Per Share||0.00|
In the last 12 months, operating cash flow was -$14.98 million and capital expenditures -$18,037, giving a free cash flow of -$15.00 million.
|Operating Cash Flow||-14.98M|
|Free Cash Flow||-15.00M|
|FCF Per Share||-$1.90|
Dividends & Yields
SKYE does not appear to pay any dividends at this time.
|Dividend Per Share||n/a|
|Dividend Growth (YoY)||n/a|
|Price Target Difference||n/a|
|Revenue Growth Forecast (5Y)||n/a|
|EPS Growth Forecast (5Y)||n/a|
The last stock split was on September 8, 2023. It was a reverse split with a ratio of 1:250.
|Last Split Date||Sep 8, 2023|